Search results
Making it easier to fly more than one airline to your destination - The Boston Globe
The Boston Globe· 48 minutes agoAccording to a Thursday notice from the US Consumer Product Safety Commission, Good Earth Lighting’s...
We must remember the heroes of the AIDS epidemic, not just the trauma
LA Times via Yahoo News· 15 hours agoWe were the caregivers, we became nurses. The young people of ACT UP, they are remembered for street...
The threat of the biopharmaceutical medical industrial complex
The Washington Times· 5 hours agoThis week, in his testimony before the House Select Subcommittee on COVID-19, Dr. Anthony Fauci...
Sheriff investigating Brian Nestande’s death as autopsy sheds light on fentanyl overdose
The Desert Sun via Yahoo News· 5 days agoShe cited a recent survey by the Johns Hopkins Bloomberg School of Public...DA has taken aggressive...
Ensysce Biosciences Announces Major Milestone for Opioid Use Disorder Program
Digital Journal· 13 hours agoDisorder ~ SAN DIEGO, CA / ACCESSWIRE / June 6, 2024 / Ensysce Biosciences, Inc. (NASDAQ:ENSC) ("Ensysce" or the "Company"), a clinical-stage pharmaceutical company developing ...
What to know about Idaho’s death penalty after Chad Daybell was sentenced to death | CNN
CNN.com· 4 days agoChad Daybell was sentenced to death for the murders of his wife and two of his second wife’s...
Moderna and MSD share encouraging three-year data from trial of melanoma therapy
Clinical Trials Arena via Yahoo Finance· 3 days agoPharmaceutical companies Moderna and Merck & Co (MSD) have announced positive results from the Phase...
Pharma Exec Indicted for Excruciatingly Detailed Death Threats Against Health Insurer
The Daily Beast· 3 days agoIn April, Baltimore-area pharmaceutical exec and Crohn’s sufferer Justin Dynlacht spoke to The New...
GSK’s Jemperli shows potential in Phase II trial for locally advanced rectal cancer
Clinical Trials Arena via Yahoo Finance· 3 days agoUK-based pharmaceutical company GSK has reported updated results from a Phase II study of Jemperli...
I-Mab and BMS assess givastomig for gastric and oesophageal cancer
Pharmaceutical Technology via Yahoo Finance· 16 hours agoIn May 2024 the European Commission approved BMS's Opdivo (nivolumab) combination with gemcitabine...